Form 4 for INAB IN8BIO, INC.
Accepted 2022-05-09 00:00:00 ET · period of report 2022-05-05 · accession 0001209191-22-027840 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-09 | 2022-05-05 | INAB | Lamb Lawrence | EVP, CSO | M - OptEx | $1.07 | +26.2K | 99.2K | +36% | +$28.0K |
| D | 2022-05-09 | 2022-05-05 | INAB | Lamb Lawrence | EVP, CSO | M - OptEx | $0.00 | -26.2K | 1,171 | -96% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-05 | M | A | 26,204 | $1.07 | 99,204 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-05-05 | M | D | 26,204 | $0.00 | 1,171 | D | $1.07 · — to 2028-11-11 | 26,204 Common Stock | (F1) The shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments commencing June 7, 2018, subject to the Reporting Person continuing to provide service through each such date. |